Skip to main content
Premium Trial:

Request an Annual Quote

Lars Eric Utterman, Eric Castaldi, Jack Jones

Premium
Lars Eric Utterman has been appointed chairman of Ludesi’s board, the company announced this week.
 
Utterman is currently president and CEO of Gyros. He is also chairman of the board for IonGate Biosciences and a member of the board at LIVC Technologies.
 
He has more than 30 years of experience at the executive level, holding various positions at GE Healthcare, Amersham Pharmacia, and Boehringer Mannheim, now part of Roche Diagnostics.
 

 
Hybrigenics this week appointed Eric Castaldi to its board as a non-executive independent director.
 
Castaldi has 20 years of financial experience especially in the medical and biotechnology fields. He is currently CFO and a member of the executive committee of pharmaceutical company NicOx, where he was in charge of its initial public offering in 1999.
 

 
Jack Jones became the CIO of the National Institutes of Health effective June 22, the agency said this week.
 

Jones will also continue as acting director of the Center for Information Technology until the NIH finds a permanent director. Jones joined NIH in 2001 as chief IT architect. In late 2003, he became acting deputy director of CIT, and in late 2005 became acting director of CIT and acting NIH CIO. Before that, he was at Sandia National Laboratories most recently as director of information processes.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.